China
BeiGene to develop $330 million biologics plant
March 7, 2017Manufacturing and Production, Research and Development BeiGene, China, Guangzhou
BeiGene, a Chinese biotech company, and Guangzhou GET Technology Development, an affiliate of Guangzhou Development District, will partner in the …
China’s insurance expansion boon to global pharma
February 23, 2017Sales and Marketing AstraZeneca, China, GSK, Shire
China has expanded the list of medicines that are covered on basic medical insurance schemes, named China’s National Reimbursement Drug …
Generic version of top-selling lung cancer drug hits Chinese market
February 20, 2017Sales and Marketing China, generics
A generic version of AstraZeneca’s Iressa (gefitinib) has been released onto the Chinese market, named Yiruike. The generic undercuts the …
WCO seizes 113m fake Indian & Chinese drugs in Africa in 10 days
February 3, 2017Manufacturing and Production, Medical Communications, Sales and Marketing Africa, China, Counterfeit drugs, India, World Customs Organisation
The World Customs Organisation (WCO) has revealed insight into the extent of the global drug counterfeiting crisis with the announcement …
Google’s life sciences business gains $800 million funding in pivot to Asia
January 27, 2017Medical Communications, Sales and Marketing China, Temasek, Verily, google
Verily, a life sciences company owned by Alphabet, Google’s umbrella company, has announced that it has received $800 million in …
Top Pharmaceutical Markets 2016: China
December 9, 2016Business Services, Manufacturing and Production, Medical Communications, Sales and Marketing China, market analysis
Originally featured in Pharmafile Autumn 2016, a report from the United States International Trade Administration sheds light on the Chinese …
Chinese investors push Kymab backing to $100 million
November 28, 2016Sales and Marketing Bill & Melina Gates Foundation, China, kymab
Kymab, the UK-based antibody biopharmaceutical group, announced that it has secured $100 million in funding. The company raised the funds …
China conducts first gene-editing human trial
November 21, 2016Research and Development, Sales and Marketing China, DNA, cas9, crispr
China has used Crispr/Cas9 gene-editing technology to edit the DNA of a human subject, suffering from metastatic lung cancer. This …
Merck KGaA invests €250 million in production in China
November 4, 2016Manufacturing and Production China, Merck KGaA, Nantong, manufacturing
Merck KGaA inaugurated their Nantong pharmaceutical plant on 4 November. At the same time, Merck also announced that it plans …
FDA issues warning letter after Chinese firm impedes investigation
November 2, 2016Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing China, FDA
The US Food and Drugs Administration (FDA) has issued a Chinese firm with a warning letter after claims it intentionally …
GSK agrees to $20m settlement for Chinese bribery allegation
October 3, 2016Business Services, Sales and Marketing China, GSK, GlaxoSmithKline
GlaxoSmithKline has agreed to settle a bribery allegation in China with a payment of $20 million to the US Securities …
80% of Chinese clinical trials’ data fabricated
September 28, 2016Manufacturing and Production, Research and Development China, Fabrication, corruption, report
The government review of clinical trial practise involved 1,622 programs of new pharmaceutical drugs waiting upon government approval to begin …
Merck says its Erbitux in combination with Folfox improves outcomes in colorectal cancer
July 4, 2016Research and Development, Sales and Marketing Cancer, China, ESMO, Merck, colorectal cancer, drug trial, research, study
Merck said late-stage trials for its Erbitux (cetuximab) in combination with Folfox significantly improved progression free survival in metastatic colorectal …
Pfizer to invest about $350 million in China biotech facility, first in Asia
June 29, 2016Research and Development, Sales and Marketing Biotech Plant, China, Pfizer, research
US pharma giant Pfizer (NYSE: PFE) said it will invest about $350 million for a global biotechnology center in the …
China to cut prices of GSK, AstraZeneca drugs
May 23, 2016Sales and Marketing AstraZeneca, China, GSK, drug prices
Chinese health authorities have announced steps to cut the prices of three costly drugs in their latest attempt to reduce …
